The pps is stuck here because the uptake has been extremely small particularly globally which was always need to value this at a MC of $500M+. Like I said, Painchek will be used mostly in Australia as the nurse are trained in APS so they are familiar in the manual process which still need to be done for 5 out of the 6 assessments but the uptake has even stalled here after the government grant.
Media Thread, page-933
-
- There are more pages in this discussion • 701 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
